Current Alzheimer Research
Title:Can Non-invasive Biomarkers Lead to an Earlier Diagnosis of Alzheimer’s Disease?
Volume: 18 Issue: 11
Author(s): Fidelia Bature, Yannis Pappas, Dong Pang and Barbara-ann Guinn*
Affiliation:
- Department of Biomedical Sciences, University of Hull, Cottingham, Hull, HU6 7RX,United Kingdom
Export Options
About this article
Cite this article as:
Bature Fidelia , Pappas Yannis , Pang Dong and Guinn Barbara-ann*, Can Non-invasive Biomarkers Lead to an Earlier Diagnosis of Alzheimer’s Disease?, Current Alzheimer Research 2021; 18 (11) . https://dx.doi.org/10.2174/1567205018666211207094630
DOI https://dx.doi.org/10.2174/1567205018666211207094630 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Synthetic Cannabinoids Phenomenon
Current Pharmaceutical Design Cognition and Emotions in Recurrent Depressive Disorders - The Role of Inflammation and the Kynurenine Pathway
Current Pharmaceutical Design Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Recent Patents on Anti-Cancer Drug Discovery Regenerative Medicine in Retina: The Future Cure
Current Tissue Engineering (Discontinued) Functional Neuroimaging of Stimulation by Music Using Positron Emission Tomography
Current Medical Imaging Pharmacological Prevention and Treatment in Clinical At-Risk States for Psychosis
Current Pharmaceutical Design Interest of α2-Adrenergic Agonists and Antagonists in Clinical Practice: Background, Facts and Perspectives
Current Topics in Medicinal Chemistry A Systems Medicine Clinical Platform for Understanding and Managing Non- Communicable Diseases
Current Pharmaceutical Design An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research
Current Drug Abuse Reviews Microfluidic Devices for Automation of Assays on Drosophila Melanogaster for Applications in Drug Discovery and Biological Studies
Current Pharmaceutical Biotechnology Combination Therapy for Multi-Target Manipulation of Secondary Brain Injury Mechanisms
Current Neuropharmacology Central Nervous System Abnormalities in Fibromyalgia and Chronic Fatigue Syndrome: New Concepts in Treatment
Current Pharmaceutical Design Alstrom Syndrome: Genetics and Clinical Overview
Current Genomics The Concept of Salience Network Dysfunction in Schizophrenia: From Neuroimaging Observations to Therapeutic Opportunities
Current Topics in Medicinal Chemistry Retinoic Acid and the Gut Microbiota in Alzheimer’s Disease: Fighting Back-to-Back?
Current Alzheimer Research Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research
Current Drug Abuse Reviews AMPA Receptor Antagonists: Potential Therapeutic Applications
Recent Patents on CNS Drug Discovery (Discontinued) GABAA Receptors in Normal Development and Seizures: Friends or Foes?
Current Neuropharmacology Assessing and Treating Cognitive Impairment in Schizophrenia: Current and Future
Current Pharmaceutical Design Schizophrenia: A Systematic Review of the Disease State, Current Therapeutics and their Molecular Mechanisms of Action
Current Medicinal Chemistry